Bonk (NASDAQ:BNKK) Announces Quarterly Earnings Results

Bonk (NASDAQ:BNKK) posted its earnings results on Wednesday. The company reported ($0.23) earnings per share for the quarter, FiscalAI reports. Bonk had a negative return on equity of 147.73% and a negative net margin of 1,553.15%.The firm had revenue of $0.79 million for the quarter.

Bonk Stock Up 4.1%

Shares of BNKK stock traded up $0.09 during trading on Friday, hitting $2.27. The company had a trading volume of 855,459 shares, compared to its average volume of 1,008,890. The business’s 50-day simple moving average is $2.65. The firm has a market cap of $17.86 million, a PE ratio of -0.29 and a beta of 1.97. Bonk has a 52 week low of $1.90 and a 52 week high of $46.90.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

Insider Transactions at Bonk

In related news, Director Mitchell Austin Rudy purchased 31,055 shares of the firm’s stock in a transaction dated Thursday, April 9th. The shares were purchased at an average price of $2.82 per share, with a total value of $87,575.10. Following the acquisition, the director directly owned 44,198 shares of the company’s stock, valued at approximately $124,638.36. This represents a 236.29% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 51.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. State Street Corp bought a new stake in Bonk during the fourth quarter worth about $33,000. Steward Partners Investment Advisory LLC purchased a new position in shares of Bonk during the 4th quarter valued at about $37,000. Jane Street Group LLC purchased a new position in shares of Bonk during the 4th quarter valued at about $96,000. Finally, Geode Capital Management LLC bought a new stake in Bonk in the 4th quarter worth approximately $128,000. Institutional investors own 12.55% of the company’s stock.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.